Search Results - abhinav+acharya

4 Results Sort By:
Formulations to Prevent Neurological Diseases and Disorders, including TBI
Traumatic brain injury (TBI) is a major source of death and long-term physical, cognitive and mental disability worldwide, with roughly 27 million new cases each year. In the U.S. alone, this results in almost 70,000 deaths, annually. Although TBIs can affect people of all ages, the risk of getting a TBI is greatest in adolescents, young adults and...
Published: 11/4/2024   |   Inventor(s): Abhinav Acharya, Sarah Stabenfeldt
Keywords(s):  
Category(s): Vaccines/Antimicrobials, Pharmaceuticals, Non-Cancer Therapeutics, Neurodegenerative Disease Technologies, Life Science (All LS Techs)
Covalent Organic Frameworks for Biomedical Applications
­ Nitric oxide (NO), and other gases, are utilized by the body to modulate immune responses in wound repair, tissue engineering, infection treatment and more. Much research has been spent developing materials that can deliver such gases in vivo, yet their labile nature makes delivery in a controlled fashion and with release of clinically relevant...
Published: 2/23/2023   |   Inventor(s): Abhinav Acharya, Arezoo Esrafili
Keywords(s):  
Category(s): Life Science (All LS Techs), Advanced Materials/Nanotechnology, Biomaterials, Pharmaceuticals
Cell-based Arrays for Screening Combination Drug Efficacy for Personalized Cancer Therapy
Arrays Require Just a Small Number of Rare Cells to Determine Best Combination of Drugs for Patient TreatmentThese cell-based arrays use a small sampling of cells to help isolate and identify a patient’s sensitivity to chemotherapeutic drugs in vitro, potentially personalizing treatment of cancer. The cancer stem cell hypothesis postulates that...
Published: 6/27/2021   |   Inventor(s): Edward Scott, Benjamin Keselowsky, Abhinav Acharya, Emina Huang, Matthew Carstens
Keywords(s):  
Category(s): Technology Classifications > Others > Others
Microarray for Efficient, Inexpensive Testing on Rare Patient-Derived Cells
Reduces Costs by Allowing Researchers to Test Multiple Agents SimultaneouslyThis cell-based microarray allows testing of a wide range of biological or pharmaceutical agents on small numbers of cells from rare populations. Patient-derived cells such as cancer cells, stem cells and precancerous cells are difficult and expensive to obtain. Inefficient...
Published: 6/27/2021   |   Inventor(s): Edward Scott, Benjamin Keselowsky, Abhinav Acharya, Emina Huang, Matthew Carstens
Keywords(s):  
Category(s): Technology Classifications > Human Health Care > Others